Literature DB >> 4125267

Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids.

J Holmgren, I Lönnroth, L Svennerholm.   

Abstract

By a double-diffusion precipitation-in-gel technique, isolated cholera toxin as well as its natural toxoid were shown to be fixed and precipitated by the ganglioside G(M1) but not by any of the related glycolipids G(M3), G(M2), G(M1)-GlcNAc, G(D1a), G(D1b), G(T1), globoside, G(A1), and tetrahexoside-GlcNAc. Twenty-five nanograms of G(M1) was enough to give a precipitation line with 1.2 mug of toxin, whereas about 50 ng was required with this amount of toxoid. G(M1) also inactivated the toxin in the ileal loop as well as in the intradermal models in rabbits. A 1: 1 molar ratio of ganglioside to toxin was found limiting, e.g., 100 pg of G(M1) could inactivate 5 ng (about 50 blueing doses) of isolated toxin. G(M1) inactivated crude toxin (culture fil rate) with the same efficiency as isolated toxin, and the inactivating capacity of G(M1) was unaffected by mixing with other gangliosides, indicating the specificity in the reaction between G(M1) and toxin. The other glycolipids tested did not inactivate toxin except G(D1a) and G(A1) which did so with approximately 1,000 times less efficiency than G(M1). This identified the portion Gal --> GalNAc [Formula: see text] as the critical region in G(M1) for toxin fixation, and it is postulated that this may be the tissue receptor structure for the cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4125267      PMCID: PMC422834          DOI: 10.1128/iai.8.2.208-214.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  CHROMATOGRAPHIC SEPARATION OF HUMAN BRAIN GANGLIOSIDES.

Authors:  L SVENNERHOLM
Journal:  J Neurochem       Date:  1963-09       Impact factor: 5.372

2.  A RAPID PERMETHYLATION OF GLYCOLIPID, AND POLYSACCHARIDE CATALYZED BY METHYLSULFINYL CARBANION IN DIMETHYL SULFOXIDE.

Authors:  S HAKOMORI
Journal:  J Biochem       Date:  1964-02       Impact factor: 3.387

3.  A slide microtechnique for the analysis of immune precipitates in gel.

Authors:  C WADSWORTH
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

4.  Diffusion-in-gel methods for immunological analysis. II.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1962

5.  Localization of cholera toxin in vivo.

Authors:  J W Peterson; J J LoSpalluto; R A Finkelstein
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

6.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

7.  Anomeric structure of globoside and ceramide grihexoside of human erythrocytes and hamster fibroblasts.

Authors:  S I Hakomori; B Siddiqui; Y T Li; S C Li; C G Hellerqvist
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

8.  Deactivation of cholera toxin by ganglioside.

Authors:  W E Van Heyningen; C C Carpenter; N F Pierce; W B Greenough
Journal:  J Infect Dis       Date:  1971-10       Impact factor: 5.226

9.  Chemical and physical properties of cholera exo-enterotoxin (choleragen) and its spontaneously formed toxoid (choleragenoid).

Authors:  J J Lospalluto; R A Finkelstein
Journal:  Biochim Biophys Acta       Date:  1972-01-26

10.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

View more
  122 in total

1.  Activation of cholera toxin-specific T cells in vitro.

Authors:  C O Elson; S Solomon
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity.

Authors:  A T Aman; S Fraser; E A Merritt; C Rodigherio; M Kenny; M Ahn; W G Hol; N A Williams; W I Lencer; T R Hirst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  Fucosylation and protein glycosylation create functional receptors for cholera toxin.

Authors:  Amberlyn M Wands; Akiko Fujita; Janet E McCombs; Jakob Cervin; Benjamin Dedic; Andrea C Rodriguez; Nicole Nischan; Michelle R Bond; Marcel Mettlen; David C Trudgian; Andrew Lemoff; Marianne Quiding-Järbrink; Bengt Gustavsson; Catharina Steentoft; Henrik Clausen; Hamid Mirzaei; Susann Teneberg; Ulf Yrlid; Jennifer J Kohler
Journal:  Elife       Date:  2015-10-29       Impact factor: 8.140

4.  Mobility of cholera toxin receptors on rat lymphocyte membranes.

Authors:  S W Craig; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

5.  Mechanism of action of cholera toxin and the mobile receptor theory of hormone receptor-adenylate cyclase interactions.

Authors:  V Bennett; E O'Keefe; P Cuatrecasaş
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

6.  Interaction of cholera enterotoxin with cultured adrenal tumor cells.

Authors:  R M Wishnow; E Lifrak; C Chen
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

7.  Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin. Relations to the mode of activation by hormones.

Authors:  V Bennett; L Mong; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-11-07       Impact factor: 1.843

Review 8.  GM1 Ganglioside: Past Studies and Future Potential.

Authors:  Massimo Aureli; Laura Mauri; Maria Grazia Ciampa; Alessandro Prinetti; Gino Toffano; Cynthia Secchieri; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2015-03-12       Impact factor: 5.590

9.  Reduction of reactivity of Escherichia coli enterotoxins by intestinal mucosal components.

Authors:  H D Cole; T E Staley; S C Whipp
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Topographic studies of gangliosides of intact synaptosomes from rat brain cortex.

Authors:  B L Hungund; S P Mahadik
Journal:  Neurochem Res       Date:  1981-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.